Skip to main content
Fig. 6 | Stem Cell Research & Therapy

Fig. 6

From: Comparison of therapeutic effects of mesenchymal stem cells from umbilical cord and bone marrow in the treatment of type 1 diabetes

Fig. 6

Change in HbA1c, exogenous insulin dosage and C-peptide in patients with T1D at 1-year follow-up. Rate of change in HbA1c (A), doses of daily insulin (B), FCP (C) and PCP (D) of the control group and MSC-treated group between baseline and 1-year follow-up. Rate of change in HbA1c (E), doses of daily insulin (F), FCP (G) and PCP (H) of the BM-MSC subgroup and UC-MSC subgroup between baseline and 1-year follow-up. Data are presented as mean ± SEM. *P < 0.05 versus the control group. FCP, fasting C-peptide; PCP, postprandial C-peptide

Back to article page

Stem Cell Research & Therapy

ISSN: 1757-6512